Effects of Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors on Relationship Between B‐Type Natriuretic Peptide and Hemoglobin Levels in Patients With Cardiorenal Anemia Syndrome
HIF-PHIs reduce BNP levels more than anticipated by the elevation of hemoglobin levels compared to oral iron supplementation. HIF-PHIs may have therapeutic benefits against heart failure beyond the correction of anemia in the heart failure patients.
Authors
- Kohtaro Abe (ORCID: https://orcid.org/0000-0003-4131-5423)
- Shintaro Kinugawa (ORCID: https://orcid.org/0000-0003-2559-0054)
- Kayo Misumi (ORCID: https://orcid.org/0000-0003-3441-1628)
- Shunsuke Katsuki (ORCID: https://orcid.org/0000-0001-7851-216X)
- Shunsuke Nakashima
- Takeo Fujino (ORCID: https://orcid.org/0000-0002-2886-3479)
- Tomoyasu Suenaga
- Kazuya Hosokawa (ORCID: https://orcid.org/0000-0003-1517-3660)
- Shouji Matsushima (ORCID: https://orcid.org/0000-0001-9774-4513)
- Takashi Kai
- Tomoaki Yoshitake
- Keisuke Shinohara (ORCID: https://orcid.org/0000-0002-3084-1711)
- Toru Hashimoto (ORCID: https://orcid.org/0000-0001-9607-0852)
- Shoei Yamamoto (ORCID: https://orcid.org/0009-0007-7740-6286)
- Kei Ikuta
Institutions
- Kyushu University (JP)
Publication Details
- Journal
- Cardiovascular Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/cdr/3143864
- Citations
- 1
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.77